Bioengineering Archives - San Diego Biotechnology Connection

Drought-tolerant corn reveals plant biotech promise in parched Midwest

Circadian clock drugs coming to treat cancer, diabetes, other diseases

‘Green’ industrial enzymes focus of Verenium’s new R

Need phylogenetic trees? Got supercomputer app for that

Amid U.S. pertussis outbreak, San Diego battling ‘whooping cough’ with

Re-evaluate your ‘references list’ before seeking biotech jobs

Transplanted stem cells restore ventricle output in heart attack patie

Medistem signs stem-cell license for diabetes treatment with Yale

Supercomputer reboot: Tackling genomics, analyzing big data

Drug discovery scientists ‘two Peters’ in $90 million Merck institute

Stock Daily Change

Biotech Events in San Diego

@SDBiotech

San Diego Biotechnology Connection

Drought tolerant corn, Monsanto, San Diego Biotechnology Connection

September 18, 2012 no comments

By Rex Graham Growing up in Iowa, the sarcastic saying we overused was something was about as exciting as watching the corn grow. But this year’s massive drought in the U.S. Corn Belt revealed Read More

Human circadian clock, San Diego Biotechnology Connection

August 13, 2012 no comments

By Rex Graham Potential circadian clock drugs with relevance to a broad spectrum of diseases from cancer and diabetes to sleep disorders are the offshoots of discoveries reported this year that expla Read More

Verenium Corporation, San Diego Biotechnology Connection

July 19, 2012 no comments

By Rex Graham Verenium Corp. (Nasdaq: VRNM), a developer of high-performance ‘”green” industrial enzymes used to produce ethanol and increase efficiency and lower pollution in anima Read More

Arman Bilge, Lexington High School, San Diego Biotechnology Connection

July 3, 2012 no comments

By Rex Graham A new Web resource developed at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego is helping thousands of researchers worldwide unravel the enigmas of Read More

Whooping cough (pertussis), San Diego Biotechnology Connection

June 1, 2012 no comments

By Rex Graham Alarmed by pertussis outbreaks this year in children in Washington, Wisconsin, Minnesota, Montana and New Mexico, public health experts in San Diego are using health text messaging to i Read More

Biotech jobs, American Institute of Biological Sciences, San Diego Biotechnology Connection

May 17, 2012 no comments

By Rex Graham When asked for references, most job seekers offer a simple list with former supervisors’ and colleagues’ contact information. But the minimalist mentions might not be best when you’re c Read More

Stemedica Cell Technologies, San Diego Biotechnology Connection

April 8, 2012 no comments

By Rex Graham Transplanted ischemic tolerant mesenchymal stem cells (itMSC) developed by San Diego-based Stemedica Cell Technologies, Inc. produced significant improvement in the pumping function of Read More

Mouse islet cells, Solimena Lab, San Diego Biotechnology Connection

March 27, 2012 no comments

San Diego-based Medistem Inc. and Yale University have signed an exclusive worldwide stem-cell license agreement covering the generation of pancreatic islets from stem cells such as the Endometrial R Read More

Allan Snavely and Mike Norman, SDSC, San Diego Biotechnology Connection

March 21, 2012 no comments

The San Diego Supercomputer Center (SDSC) at UC San Diego has completed a supercomputer reboot as a center of expertise on genomics and analysis of large medical data sets. You can call it a three-ye Read More

The Two Peters: Peter S. Kim and Peter G. Schultz, San Diego Biotechnology Connection

March 18, 2012 no comments

By Rex Graham “The two Peters” is a suddenly popular term among San Diego drug-discovery scientists excited about the formation of a new drug-discovery research institute in La Jolla. This disruptive Read More

1 2 Next »

ADMP	0.675	+0.007
AEMD	0.0961	-0.0089
AHRO	0.73	0.00
AIMM	0.0035	0.00
AMGN	104.43	+0.19
ANX	0.733	0.00
APRI	3.2901	-0.1199
ARNA	7.9325	-0.0575
ATEC	1.91	-0.04
AVNR	3.239	-0.031
AVTO	0.005	0.00
AXMP	0.015	+0.003
AXRX	0.16	0.00
CADX	6.69	-0.30
CELG	123.60	+0.10
CORX	0.045	+0.005
CXM	0.095	+0.004
CYTX	2.51	-0.03
CYTR	2.31	-0.11
DRAD	2.35	-0.09
DXCM	20.5112	-0.6188
ENTB	0.0016	-0.0004
FOLD	3.40	-0.06
HALO	7.22	-0.37
HRBR	0.1601	-0.0286
IAGXQ	0.14	0.00
ILMN	70.50	-2.08
IMBI	0.028	0.00
ISCO	0.295	-0.005
ISIS	20.70	-0.11
IVRO	0.017	0.00
LGND	26.98	-0.76
LIFE	73.97	+0.29
LJPC	0.077	+0.002
LPTN	4.905	+0.005
MCK	117.76	-0.65
MEDS	1.10	-0.10
MEIP	8.44	-0.04
MLPH	0.018	0.00
MNKD	6.1776	+0.8176
MNOV	3.19	+0.01
MRIC	1.13	-0.05
NAII	4.68	0.00
NBIX	12.0101	-0.0499
NRDCQ	0.0001	0.00
NUXP	0.0016	0.00
ONCS	0.31	-0.0105
OPTR	14.51	+0.08
OREX	6.14	+0.03
PCRX	29.08	+0.24
PFE	29.38	+0.60
QDEL	21.99	-0.66
RHHBY	65.66	+0.95
RMD	49.76	-0.32
SNTS	22.39	+0.09
SQNM	3.91	-0.15
TSRX	7.61	-0.16
VOLC	16.70	-0.04
VRX	74.88	-0.65
VRNM	2.14	-0.01
VVUS	13.395	+0.235
ZGNX	1.51	-0.01

2013-05-22 14:21

Trius Therapeutics: New, Positive Dimension For Investment Outlook http://t.co/rcVXC57kkN $CBST $TEVA $TSRX
9 days ago
Retweet
@ilus_art Gorgeous way to celebrate art, biology and cells.
17 days ago
Retweet
Trius Therapeutics releases persuasive safety study of potent new antibiotic against MRSA #superbug. http://t.co/uRBiPHj14U
23 days ago
Retweet
Halozyme initiates Phase 2 trial of drug to treat stage 4 pancreatic cancer. http://t.co/U9cjxGbtIL
29 days ago
Retweet
Illumina’s stronger than expected revenue up 21% sends shares up 13%. http://t.co/qviU0MYLQ3
29 days ago
Retweet
Trius presenting clinical-trial results Apr. 27 http://t.co/MCFeBYi57w on tedizolid, a potent MRSA antibiotic. http://t.co/myB421ZD2n
29 days ago
Retweet
After Thermo Fisher Scientific buys Life Technologies, sequencing leader Illumina may finally sell. http://t.co/F92ndBP0z2
37 days ago
Retweet
http://t.co/y8xbsAQ4q8
61 days ago
Retweet
FDA reviewing diabetes drugs causing pancreas precancers. Affected: Lilly, Merck, Novo Nordisk, Bristol-Myers. http://t.co/2dPyRAYLsc
68 days ago
Retweet

23 Events on May 23, 2013 Studies Toward the Synthesis of Antitumor Natural Products Starts: 4:00 pm Ends: May 23, 2013 - 5:00 pm Location: Scripps Research Inst. - Green Hospital Building, Valerie Timken Amphitheater Description: Distinguished Lecture Series Speaker: John A. Porco, Ph.D., Professor, Department of Chemistry, Boston University Read More: <a href="http://pubs.rsc.org/en/content/articlelanding/2013/np/c3np20122h">link</a> More details...

The share price of Trius Therapeutics (TSRX) has rebounded almost fully from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty about the company’s lead investigational drug is a lingering February hangover. Small investors face a dilemma: should they dump their diluted shares, double down? Our story explains why we recommend doubling down: http://sandiegobiotechnology.com/topics/5733/trius-dump-or-double-down-on-maker-of-mrsa-antibiotic/
100 days ago
A Glaxo Smith Kline genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc., and San Diego-based Vical, Inc., offer new hope. http://sandiegobiotechnology.com/topics/5600/glaxo-genital-herpes-vaccine-flops-but-genocea-a-buy-in-vaccine-space/
159 days ago
The Dow was off 1.82 percent, down 243.36 points to 13,102.53 at the close of trading Oct. 23 amid disappointing earnings reports. But 11 publicly traded San Diego biotechs gained for the day. https://sandiegobiotechnology.com/topics/5443/eleven-san-diego-biotech-stocks-rise-amid-tuesday-plunge-in-dow/
211 days ago
Millions of infertile women will soon get the biggest baby boost in a generation from preimplantation genetic diagnosis (PGD), which identifies their healthiest embryos at in vitro fertilization (IVF) clinics. These blastocysts, embryos with 50-150 cells, are at a very favorable stage for implantation and pregnancy. The inner cell mass will give rise to the actual cells of the fetus. The other cells that surround and protect the inner cell mass give rise to the fetal part of the placenta. Photo: Robert Shabanowitz, Gesinger Medical Center
212 days ago
It’s more than a 5-hour energy jolt. Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network will give the San Diego biotech company a permanent sales boost for its own nutritional supplements -- and a larger piece of the $30 billion supplements market. https://sandiegobiotechnology.com/topics/5393/cardium-boosts-energy-supplement-sales-with-national-marketing-muscle/
232 days ago